文献速递产科母胎医学

产前糖皮质激素给药的最佳时机与早产儿及幼儿期结局

Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2019-12-17

基于两项前瞻性多中心研究的二次分析,纳入2259例单胎早产儿,比较产前糖皮质激素给药至分娩间隔与结局。分娩前2至<7天给药者呼吸窘迫综合征风险最低,≥14天给药与严重新生儿及幼儿期病率风险升高相关。

要点

  • 分娩前2至<7天接受产前糖皮质激素者呼吸窘迫综合征发生率最低(51.3%)。
  • 与2至<7天相比,<2天、7至<14天和≥14天给药者呼吸窘迫综合征调整比值比分别为2.07、1.40和2.34。
  • ≥14天给药与严重新生儿病率(aOR 1.57)和幼儿期病率(aOR 1.74)风险升高相关。

核心结论

  • 分娩前2至<7天接受产前糖皮质激素的早产儿呼吸窘迫综合征风险最低,给药至分娩间隔短于或长于该窗口均与风险升高相关。
  • 与2至<7天给药相比,≥14天给药与严重新生儿病率和幼儿期病率风险升高相关。
  • 作者认为这些结果强调优化产前糖皮质激素给药时机对改善短期和长期结局的重要性。

研究设计与样本

  • 研究类型为两项前瞻性多中心研究的二次分析,研究分别为Genomics and Proteomics Network for Preterm Birth Research(2007年11月至2011年1月)和Beneficial Effect of Antenatal Magnesium(1997年12月至2004年5月)。
  • 纳入单胎妊娠、接受产前糖皮质激素且在23 0/7至33 6/7周分娩的产妇,排除接受≥1个疗程糖皮质激素者。
  • 共2259例受试者纳入分析,按首次产前糖皮质激素给药至分娩间隔分为<2天(622例,27.5%)、2至<7天(821例,36.3%)、7至<14天(401例,17.8%)和≥14天(415例,18.4%)四组。
  • 主要结局为呼吸窘迫综合征,次要结局包括复合新生儿病率和幼儿期病率,采用多变量logistic回归估计关联。

主要发现

  • 分娩前2至<7天接受产前糖皮质激素者呼吸窘迫综合征发生率最低(51.3%),<2天、7至<14天和≥14天组分别为62.7%、55.9%和57.6%(p<0.001)。
  • 与2至<7天给药相比,<2天给药者呼吸窘迫综合征调整比值比aOR 2.07(95%CI 1.61-2.66),7至<14天给药者aOR 1.40(95%CI 1.07-1.83),≥14天给药者aOR 2.34(95%CI 1.78-3.07)。
  • 与2至<7天给药相比,≥14天给药者严重新生儿病率aOR 1.57(95%CI 1.12-2.19),幼儿期病率aOR 1.74(95%CI 1.02-2.95)。
  • <2天或7至<14天给药与严重新生儿病率或严重幼儿期病率无显著关联。
  • 多数受试者(78.1%)为特发性自发性早产或未足月胎膜早破后分娩,平均孕周29.5±2.8周。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antenatal corticosteroids reduce morbidity and mortality among preterm neonates. However, the optimal timing of steroid administration with regards to severe neonatal and early childhood morbidity is uncertain. OBJECTIVE: To evaluate the association between the timing of antenatal corticosteroid adminstration and preterm outcomes. We hypothesized that neonates exposed to antenatal corticosteroids 2 to <7 days before delivery would have the lowest risks of neonatal and childhood morbidity. STUDY DESIGN: Secondary analysis of two prospective multicenter studies enriched for spontaneous preterm birth, Genomics and Proteomics Network for Preterm Birth Research (11/2007-1/2011) and Beneficial Effect of Antenatal Magnesium (12/1997-5/2004). We included women with singleton gestations who received antenatal corticosteroids and delivered at 23 0/7-33 6/7 weeks' gestation. Women who received ≥1 course of corticosteroids were excluded. Neonatal outcomes were compared by the timing of the first dose of antenatal corticosteroids in relation to delivery: <2 days, 2 to <7 days, 7 to <14 days, and ≥14 days. The primary outcome was respiratory distress syndrome. Secondary outcomes included composite neonatal morbidity (death, intraventricular hemorrhage grade III or IV, periventricular leukomalacia, bronchopulmonary dysplasia, or necrotizing enterocolitis), and early childhood morbidity (death or moderate to severe cerebral palsy at age 2). Multivariable logistic regression estimated the association between timing of antenatal corticosteroid administration and study outcomes. RESULTS: A total of 2,259 subjects met inclusion criteria: 622 (27.5%) received antenatal corticosteroids <2 days before delivery, 821 (36.3%) 2 to <7 days, 401 (17.8%) 7 to <14 days, and 415 (18.4%) ≥14 days. The majority (78.1%) delivered following idiopathic spontaneous preterm labor or preterm premature rupture of membranes at a mean gestational age of 29.5 +/-2.8 weeks. Neonates exposed to antenatal corticosteroids 2 to <7 days before delivery were the least likely to develop respiratory distress syndrome (51.3%), compared to those receiving antenatal corticosteroids <2 days, 7 to <14 days, and ≥14 days before delivery (62.7%, 55.9%, and 57.6%, respectively, p<0.001). Compared to receipt 2 to <7 days before delivery, there was an increased odds of respiratory distress syndrome with receipt of antenatal corticosteroids <2 days (aOR 2.07, 95%CI 1.61-2.66), 7 to <14 days (aOR 1.40, 95% CI 1.07-1.83), and ≥14 days (aOR 2.34, 95%CI 1.78-3.07). Neonates exposed to antenatal corticosteroids ≥14 days before delivery were at increased odds for severe neonatal morbidity (aOR 1.57, 95%CI 1.12-2.19) and early childhood morbidity (aOR 1.74, 95%CI 1.02-2.95), compared to those exposed 2 to <7 days before delivery. There was no significant association between antenatal corticosteroid receipt <2 days or 7 to <14 days and severe neonatal morbidity or severe childhood morbidity. CONCLUSIONS: Preterm neonates exposed to antenatal corticosteroids 2 to <7 days before delivery had the lowest odds of respiratory distress syndrome, compared to shorter and longer time intervals between steroid administration and delivery. Antenatal corticosteroid administration ≥14 days before delivery is associated with an increased odds of severe neonatal and childhood morbidity, compared to 2 to <7 days before delivery. These results emphasize the importance of optimally timed antenatal corticosteroids to improve both short- and long-term outcomes.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Battarbee AN, Ros ST, Esplin MS, et al. Optimal timing of antenatal corticosteroid administration and preterm neonatal and early childhood outcomes. Am J Obstet Gynecol MFM. 2019. PMID: 32905377. doi:10.1016/j.ajogmf.2019.100077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。